Will Sage Therapeutics Inc (SAGE) benefit from Wall Street bulls Calls?

Sage Therapeutics Inc (NASDAQ: SAGE) is -19.18% lower on its value in year-to-date trading and has touched a low of $4.62 and a high of $13.47 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SAGE stock was last observed hovering at around $9.21 in the last trading session, with the day’s gains setting it 0.06%.

Currently trading at $9.27, the stock is 3.80% and 21.32% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.06 million and changing 0.65% at the moment leaves the stock 32.13% off its SMA200. SAGE registered 70.72% gain for a year compared to 6-month gain of 55.02%. The firm has a 50-day simple moving average (SMA 50) of $7.641 and a 200-day simple moving average (SMA200) of $7.01595.

The stock witnessed a 32.62% loss in the last 1 month and extending the period to 3 months gives it a 33.96%, and is 0.76% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.35% over the week and 1.95% over the month.

Sage Therapeutics Inc (SAGE) has around 353 employees, a market worth around $580.51M and $47.40M in sales. Profit margin for the company is -747.61%. Distance from 52-week low is 100.65% and -31.18% from its 52-week high. The company has generated returns on investments over the last 12 months (-84.40%).

with sales reaching $16.69M over the same period.The EPS is expected to grow by 44.94% this year, but quarterly earnings will post 100.08% year-over-year. Quarterly sales are estimated to grow 92.87% in year-over-year returns.

Sage Therapeutics Inc (SAGE) Top Institutional Holders

254.0 institutions hold shares in Sage Therapeutics Inc (SAGE), with institutional investors hold 93.36% of the company’s shares. The shares outstanding are 62.54M, and float is at 55.09M with Short Float at 5.09%. Institutions hold 83.65% of the Float.

The top institutional shareholder in the company is VANGUARD GROUP INC with over 6.42 million shares valued at $69.68 million. The investor’s holdings represent 10.5988% of the SAGE Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 5.82 million shares valued at $63.24 million to account for 9.6193 of the shares outstanding. The other top investors are RTW INVESTMENTS, LP which holds 5.48 million shares representing 9.0531% and valued at over $59.52 million, while BLACKROCK INC. holds 8.6154 of the shares totaling 5.22 million with a market value of $56.64 million.

Sage Therapeutics Inc (SAGE) Insider Activity

Related Posts

News RTS
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.